Proteomic Assessment of Preterm Birth
- Conditions
- Preterm Birth
- Registration Number
- NCT01371019
- Lead Sponsor
- Sera Prognostics, Inc.
- Brief Summary
The purpose of this study is to to collect and store blood samples that will be utilized to develop a multimarker test to predict preterm delivery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 5500
- Subject is 18 years or older.
- Subject has a singleton pregnancy.
- Subject is able to provide consent.
- Subject is pregnant with more than one fetus.
- There is a known or suspected fetal anomaly.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Spontaneous Preterm Birth August 2015
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (13)
Christiana Care Health System
🇺🇸Newark, Delaware, United States
University of North Carolina at Chapel Hill
🇺🇸Chapel Hill, North Carolina, United States
Oregon Health and Science University
🇺🇸Portland, Oregon, United States
Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States
Baystate Medical Center
🇺🇸Springfield, Massachusetts, United States
Intermountain Medical Center Suite 100, 5121 S. Cottonwood Street ,
🇺🇸Murray, Utah, United States
Maricopa Integrated Health System
🇺🇸Phoenix, Arizona, United States
San Diego Perinatal Clinic
🇺🇸San Diego, California, United States
McKay-Dee Hospital Center
🇺🇸Ogden, Utah, United States
Ohio State University
🇺🇸Columbus, Ohio, United States
Regional Obstetrical Consultants
🇺🇸Chattanooga, Tennessee, United States
University of Texas Medical Branch at Galveston
🇺🇸Galveston, Texas, United States
LDS Hospital
🇺🇸Salt Lake City, Utah, United States